Filing Details
- Accession Number:
- 0001491877-10-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-19 13:00:00
- Reporting Period:
- 2010-05-17
- Filing Date:
- 2010-05-19
- Accepted Time:
- 2010-05-19 14:44:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 72444 | Nabi Biopharmaceuticals | NABI | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428524 | D. Paul Kessler | C/O Nabi Biopharmaceuticals 12276 Wilkins Ave Rockville MD 20852 | Svp Clinical, Med. & Reg.; Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-05-17 | 300 | $5.68 | 112,952 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 50 | $5.69 | 112,902 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 850 | $5.69 | 112,052 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 1,000 | $5.70 | 111,052 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 3,205 | $5.70 | 107,847 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 700 | $5.71 | 107,147 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 3,592 | $5.71 | 103,555 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 100 | $5.72 | 103,455 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 1,900 | $5.72 | 101,555 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 100 | $5.73 | 101,455 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 1,400 | $5.73 | 100,055 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 1,003 | $5.74 | 99,052 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 600 | $5.75 | 98,452 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-17 | 200 | $5.76 | 98,252 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
Billionaire Hedge Funds
